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Abstract.  The initial step in extravasation of neutro- 
phils (polymorphonuclear leukocytes [PMNs]) to the 
extravascular space is adherence to the endothelium. 
We examined the effect of oxidants on this process 
by treating human endothelial cells with H202, 
t-butylhydroperoxide, or menadione. This resulted in a 
surface adhesive for PMN between 1 and 4  h after ex- 
posure. The oxidants needed to be present only for a 
brief period at the initiation of the assay. Adhesion 
was an endothelial cell-dependent process that did not 
require an active response from the PMN.  The adhe- 
sive molecule was not platelet-activating factor, which 
mediates PMN adherence when endothelial cells are 
briefly exposed to higher concentrations of H202 
(Lewis, M.  S., R. E. Whatley, P.  Cain, T.  M. Mcln- 
tyre, S.  M. Prescott, and G.  A.  Zimmerman. 1988. J. 
Clin.  Invest.  82:2045-2055),  nor was it ELAM-1, an 
adhesive glycoprotein induced by cytokines. Oxidant- 
induced adhesion did not require protein synthesis, 
was inhibited by antioxidants, and, when peroxides 
were the oxidants, was inhibited by intracellular iron 
chelators. 
Granule membrane protein-140  (GMP-140)  is a 
membrane-associated glycoprotein that can be translo- 
cated from its intracellular storage pool to the surface 
of endothelial cells where it acts as a ligand for PMN 
adhesion (Geng, J.-G., M. P. Bevilacqua, K. L. Moore, 
T. M. Mclntyre, S. M. Prescott, J. M. Kim, G. A. Bliss, 
G.  A. Zimmerman, and R. P.  McEver.  1990. Nature 
(Lond).  343:757-760).  We found that endothelial cells 
exposed to oxidants expressed GMP-140  on their sur- 
face, and that an mAb against GMP-140  or solubilized 
GMP-140 completely blocked PMN adherence to 
oxidant-treated endothelial cells. Thus, exposure of en- 
dothelial cells to oxygen radicals induces the 
prolonged expression of GMP-140 on the cell surface, 
which results in enhanced PMN adherence. 
EUKOCYTES circulate  in the blood,  yet their function, 
mediation of inflammatory reactions and attenuation 
of infection, is manifested in the extravascular space. 
This results from the directed migration of polymorphonu- 
clear leukocytes  (PMNs) ~ and monocytes into infected or 
perturbed areas by an exquisitely regulated communication 
between the circulating leukocytes and the endothelial cells 
that form the interface between blood and the extravascular 
space. Activated endothelial cells express several molecules 
that induce unactivated PMN to bind to them. Stimulation 
of endothelial  cells  for several hours with tumor necrosis 
factor-or (TNF-c0, intedeukin-1, or endotoxin (3) causes en- 
dothelial cells to bind PMN.  This process is dependent on 
1.  Abbreviations  used in this paper:  ELAM-1,  endothelial-leukocyte  ad- 
hesion molecule-l; HBSS/A,  HBSS containing 0.5%  human serum albu- 
min; PAF, platelet-activating  factor; PMN, polymorphonuclear leukocyte; 
t-BuOOH, tert-butylhydroperoxide;  TNF-c~, tumor necrosis factor-or; vWF, 
von Willebrand factor. 
new protein synthesis, and, depending on the time of stimu- 
lation, is mediated by the surface expression of endothelial 
leukocyte adhesion molecule-1 (ELAM-1) (3), a member of 
the recently identified selectin (7,20) family. There are also 
mechanisms  that act  more  rapidly  to  induce  endothelial 
cell-dependent PMN adhesion.  One  is unique in that the 
mediator, platelet-activating factor (PAF), is a phospholipid. 
Endothelial cells do not normally contain PAF, but synthe- 
size appreciable amounts of it within minutes of appropriate 
stimulation (23, 24, 40). While all of this PAF remains as- 
sociated with the endothelial cell (30), a portion of it is ex- 
pressed on the endothelial cell surface where it is recognized 
by the PMN receptor for PAF (42). This endothelial cell-de- 
pendent adhesion process requires activation of the PMN by 
endothelial cell-associated PAF and the functional upregula- 
tion of the PMN CDll/CD18 adhesive glycoprotein  2 (42). 
2.  Zimmerman, G. A.,  K.  D. Patel, S. M.  Prescott, R. E  McEver,  and 
T. M. McIntyre, manuscript submitted for publication. 
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PMN adhesion is demonstrated by endothelial cells stimu- 
lated with phorbol esters (7), or rapidly acting agonists like 
thrombin and histamine  ~ through the expression of a second 
member of the selectin family of adhesive receptors for leu- 
kocytes.  These  rapidly acting agonists transiently induce 
translocation of the  adhesive glycoprotein GMP-140  (20) 
(also known as PADGEM protein; 5, 3) from specialized in- 
tracellular granules, the Weibel-Palade bodies, to the sur- 
face  of the  stimulated cells  (5,  9,  21).  PMNs  adhere  to 
purified,  immobilized GMP-140 and to  COS  cells  trans- 
fected with its cDNA (7).  Both PAF and GMP-140 are ex- 
pressed by endothelial cells stimulated with rapidly acting 
agonists, where they act in concert to mediate maximal PMN 
adherence.  2 
PMN adherence and recruitment appear to play a critical 
role in the oxidant-induced tissue injury that accompanies a 
variety of pathologic processes  (15,  19,  32).  In many in- 
stances, PMNs are attracted into the affected area by the ini- 
tial insult and then exacerbate the tissue damage by releasing 
a  variety of injurious agents, including H202.  The mecha- 
nisms by which PMNs infiltrate areas subjected to oxidant 
damage are not completely defined. However, this process is 
a major pathologic one as about half of the damage observed 
upon reperfusion of ischemic tissue is prevented by either 
removing circulating PMN or inhibiting their function, by 
treatment with a variety of antioxidants, or by chelation of 
transition metals such as ionic iron (8).  We observed (14) 
that  H202  itself is  an  agonist  for  PAF  synthesis by  en- 
dothelial cells, and that it also induced PMN adherence to 
these cells. These responses occurred within minutes of ex- 
posure  to  H202,  providing that  the  concentration was  at 
least 1 mM, and PMN adhesion was completely dependent 
on the PAF-mediated mechanism. 
Recently Nathan (27,  28) observed that activated leuko- 
cytes, if they have spread onto a favorable surface, generate 
large amounts of oxygen radicals for prolonged periods of 
time. This raised the possibility that endothelial cells may be 
exposed to relatively high concentrations  of oxidants for sev- 
eral hours. Indeed, activation of 107 PMN in the presence 
of endothelial cells generated H202 equivalent to 0.3 mM 
(34), while other studies (reviewed in 14) have shown that 
endothelial  ceils  are  exposed  to  oxidants  for  prolonged 
periods in hyperoxic pulmonary injury and other pathologic 
states. Furthermore, PMN accumulate at the intimal surface 
in these conditions (1, 6). We report that endothelial cells ex- 
posed for  1--4 h  to submillimolar concentrations of H202, 
or  other  oxidants,  bound  significant numbers  of  PMN. 
Prolonged surface expression of GMP-140 was  solely re- 
sponsible for this process,  and therefore was unlike PMN 
adhesion in response to receptor-mediated agonists where 
GMP-140 expression is only transient, and is only partially 
responsible for PMN adhesion. This is a new mechanism for 
PMN adhesion to endothelium in which a pathologic agonist 
induces unregulated expression of a proadhesive molecule. 
Materials and Methods 
Materials 
HBSS and M199 were from Whittaker M. A. Bioproducts (Walkersville, 
MD), and human  serum  albumin  (25%) was from Miles Laboratories, Inc. 
(Elkhart, IN). Purified  human  thrombin  was the kind gift of Dr. John Fen- 
ton (Albany,  NY), and recombinant  human  TNF-tx  was provided  by Genen- 
tech, Inc. (San Francisco, CA). GMP-140 was solubilized  and purified as 
described (7). PAF was from Avanti  Polar Lipids, Inc. (Birmingham,  AL). 
[3H]Acetate was from New England Nuclear (Boston, MA), and mIn- 
oxine was purchased from the Radiopharmacy Service  at the University  of 
Utah. I.,659,989 was the kind gift of John Chabala of Merck, Sharp and 
Dohme Research (Rahway, NJ) and WEB 2086 was kindly provided by 
Peggy Oanong  of Boehringer Ingelheim  Pharmaceuticals,  Inc. (Ridgefield, 
CT). mAbs H18/7 and 60.3 were generously  donated by Michael Bevil- 
acqua (Boston, MA), and Patrick Beatty and John Harlan (Seattle, WA), 
respectively. 2L7'-,Bis-(2-carboxyethyl)-5-(and-6)  carboxyfluorescein,  acet- 
oxymethyl ester, and propidium  iodide were from Molecular Probes (Eu- 
gene, OR). Ascorbate was from Eastman Kodak Co.  (Rochester, NY). 
Other reagents were obtained  from Sigma Chemical Co. (St. Louis, MO). 
Cell Isolation and Culture 
Human umbilical  vein endothelial  cells were cultured in 24-mm  multiwell 
plates (Costar Data Packaging  Corp., Cambridge,  MA) as described (40). 
Only monolayers  of primary cultures  that were tightly confluent  were used 
for these studies. Human intestinal  smooth muscle cells (CRL 1692) and 
HL60 cells  were obtained  from  the American  Type  Culture  Collection.  HL- 
60 cells were  cultured  as described  (42). PMN were isolated  from fresh hu- 
man blood and labeled with mIn-oxine  as described (40). 
Cell Adhesion and Labeling Techniques 
Endothelial cells were treated with HBSS containing  0.5% human serum 
albumin (HBSS/A) and various agonists for the stated period of time, 
washed twice with HBSS and the adherence of mIn-PMN or tlqn-HL-60 
cells to monolayers  of endothelial  cells was performed as described (40, 
42). Synthesis  of PAF was determined  by following  the incorporation  of 
[3H]acetate into a phospholipid that comigrated with PAF on thin-layer 
chromatography plates  as described  (23). This product  previously  has been 
shown to be authentic  PAF (30). The effects of PAF receptor antagonists 
were examined  following  a 5-min preexposure of PMN to the antagonists 
as  described (42). Endothelial cells were labeled with 2;7Lbis-(2  - 
carhnxyethyl)-5-(and-6)carboxyfluorescein,  acetoxymethyl ester (CFAM) 
by incubating  the monolayers  with 2.8 #M CFAM for 5 min at 37  °. The 
monolayers were then washed with HBSS and incubated  in this buffer for 
an additional  2 min to allow hydrolysis  of the ester bond. The monolayers 
were then washed twice with HBSS before agonist  addition. Propidium  io- 
dide and trypan blue exclusion were determined by exposing control or 
oxidant-treated  monolayers  to 50 #M propidium  iodide  or 0.4 % trypan  blue 
for 5 min. The monolayers  were washed twice with HBSS and then visual- 
ized by fluorescence microscopy using a Nikon DM580/61-A filter cube 
when propidium  iodide  was the dye. Endothelial  cell monolayers  were fixed 
with glutaraldehyde  by exposing washed monolayers  to 2.5% glutaralde- 
hyde for 30 min. Microwave  fixation  (2) of monolayers  was performed for 
1 min in a Litton  microwave  set at maximum  irradiation.  PMNs were fixed 
by collecting  freshly isolated PMN (5.5 x  106/mi  in HBSS/A) by centrifo- 
gation at 1,350 g for 5 rain, resuspending  them in 5x the original volume 
of ice-cold  2% formaldehyde  for 5 min, and then reisolating  them by cen- 
trifugation. They were then resuspended at the original concentration  in 
HBSS/A. Protein synthesis  was inhibited  in endothelial  cell monolayers  by 
incubating  the monolayers  with 5/~g/ml actinomycin  D or 5 #M emetine 
for  15  min at  37 °  before addition of the  experimental agent. These 
monolayers, in the continued  presence of actinomycin  D or emetine, were 
incubated for 2 h before the effect of the inhibitors  on adhesion was deter- 
mined. 
The effect of the blocking anti-GMP-140  mAb (31 or the nonblocking 
monoclonal  anti-GMP-140  antibody  S12 (7) on PMN adherence  was exam- 
ined by exposing endothelial  cell monolayers  to buffer or experimental 
agents for the stated time, and then incubating  the monolayer  with 10/zg/ml 
of the purified antibody  for 10 rain. The antibody  was removed, and fresh 
antibody  and mIn-PMN were added to determine  adherence. The effect of 
purified GMP-140 or fibrinogen  was examined  by exposing mIn-PMN to 
5 ~g/ml  of either protein  for 20 rain before initiation  of the adherence  assay, 
which also contained  these proteins  at this concentration.  All experiments, 
except that performed with limited  amounts  of H18/7, have been performed 
a minimum  of two times with equivalent  results. 
Binding  of S12 to endothelial  cell monolayers  was measured by incubat- 
ing the monolayers with HBSS/A with or without ngonist for the stated 
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Figure 1. PMN adherence to human endothelial cells treated with t-BuOOH or H202 as a function of (A) concentration or (B) time. Pri- 
mary cultures of human umbilical vein endothelial cells were treated (.4) with HBSS/A, or the stated concentration of t-BuOOH or H202 
in HBSS/A for 2 h at 37  ° or (B) HBSS/A without or with 250 #M t-BuOOH, 250 #M H202, or 500 U/ml TNF-c~ for the stated time. 
After incubation,  the medium was removed, and the monolayers were washed twice. PMN adhesion to the endothelial cell monolayers 
was then determined by layering 2.5  x  106 mIn-PMN over the endothelial cells and incubating them for 15 rain at 37  °. Nonadherent cells 
were removed and loosely adherent cells were collected with two washes. Adherent cells were solubilized with 1 M NIL,OH and rain-la- 
beled material was recovered for determination of gamma radioactivity. The values presented are the percent of PMN that bound, compared 
to the total added to each well, and are given as a mean and range of duplicate values. 
period of time before this medium was removed and the monolayer fixed 
with 1% formaldehyde (9). The fixed monolayers were washed thrice with 
HBSS, and then incubated with 2 t~g/ml S12 or isotyped-matched  T10 (anti- 
gpHb/IIIa) (22)  for 45  rain at 25 °. These antibodies were removed, the 
monolaycr washed thrice with HBSS, and then the monolayer was incubated 
with ~25I-labeled sheep anti-mouse IgG (1/100 dilution; Amersham Corp., 
Arlington Heights, IL) for 20 rain at 25 °  Unbound antibody was removed 
with three washes of HBSS/A before the label was solubilized with  1N 
NI-LOH  and  quantitated  by  gamma  counting.  Adherence of PMN  to 
monolayers incubated in parallel was performed as described above. 
Release of yon Willebrand Factor (vWF) was quantitated by ELISA by 
coating microtiter dishes with 10 #g/mi rabbit antihuman vWF (Behring Di- 
agnostics, La Jolla, CA) during an overnight incubation at 4 °. These wells 
were washed four times with PBS (pH 7.2)  containing 0.05%  Tween-20 
(PBS/T), and then incubated with either 1]10 dilutions (into PBS containing 
1% BSA) of supematants of endothelial cells treated with HBSS/A with or 
without 250 #M t-BuOOH for the stated time, or with various concentra- 
tions of human vWF (the kind gift of Gerald Reth, University of Washing- 
ton, Seattle, WA). After 90 min at 37 °, the wells were washed six times with 
PBS/T, and then incubated for 90 rain at 37 ° with a 1/1,000 dilution of goat 
antihuman vWF IgG (Atlantic Antibodies, Scarborough, ME). These wells 
were then washed six times with PBS/T, incubated for 90 rain at 37 ° with 
a  1/1,000 dilution of rabbit anti-goat IgG conjugated to HRP (type VI; 
Sigma Chemical Co.). The wells were washed six times with PBS/T and 
incubated for 20 rain at 37 ° with o-phenylenediamine (0.1 ml at 0.4 mg/ml) 
before the reaction was  stopped with 8N  H2SO4.  Bound  antibody was 
quantitated by determining the optical density at 492 nm. 
Results 
Peroxides Induce Human Endothelial Cells to 
Bind PMN 
We previously observed (14)  that exposure of endothelial 
cells to millimolar concentrations  of H202  rapidly  stimu- 
lates  the  synthesis  of PAF,  and  induces  the  adherence  of 
PMN. Adhesion of PMN under these circumstances is medi- 
ated by PAF synthesized and expressed by the endothelial 
cells (40). The data in Fig.  1 show that much lower concen- 
trations  of H202  also  induced  the  adherence  of PMN  to 
monolayers of endothelial cells if the incubation was pro- 
longed. The optimal concentration of H20: lay between 150 
and 350 #M when the incubation time was 2 h  (Fig.  1 a). 
Alteration of the endothelial cell surface in response to H202 
developed rapidly with maximal PMN adherence occurring 
after 1-3 h of continuous incubation with H20~ (Fig.  1 b). 
Adherence  at these  times  was  completely independent  of 
PAF accumulation (vide infra), and therefore differs from the 
mechanism that we previously elucidated. 
We next investigated the effect of a lipid-soluble peroxide, 
t-BuOOH, on human endothelial cells. We found that it too 
stimulated these cells to bind PMN  with  a  concentration 
relationship like that of H20~ (Fig.  la).  The magnitude of 
the endothelial cell-dependent adhesion in response to this 
peroxide was equivalent to that induced by TNF-cx, which, 
in general, was greater than that in response to agents such 
as thrombin (41).  The time relationship of PMN adhesion 
also was similar to that of HzO2 (Fig.  lb), except that,  al- 
though not shown in this experiment, there was no adherence 
to endothelial cells treated with t-BuOOH for 30 rain or less. 
The generation  of an  adhesive surface on the  endothelial 
cells in response to t-BuOOH was considerably faster than 
that induced by TNF-c~ (Fig.  1), but was much slower than 
that induced by thrombin (40),  histamine  2 or high concen- 
trations of H20: (14). 
The endothelial cell monolayer did not need to be exposed 
to HzO2 or t-BuOOH continuously in order to induce PMN 
adhesion.  When endothelial cells were pulsed for 15 or 30 
rain with t-BuOOH and then incubated in the absence of ex- 
ogenous peroxide for 105 or 90 rain, for a total of 2 h of incu- 
bation, the amount of adherence was 36 and 116%, respec- 
tively, of that in response to a continuous 2-h exposure to 
t-BuOOH (Fig.  2).  The same protocol using H2Oz as the 
oxidant  showed  that  it,  too,  did  not  have  to  be  present 
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Figure 2.  Effect of a single pulse of H20: or t-BuOOH on subse- 
quent PMN adhesion to endothelial  cells.  Endothelial  cell mono- 
layers were either treated continuously with 250 #M t-BuOOH or 
H20~, or were treated  for 15 or 30 min at the initiation  of the ex- 
periment. The peroxide was then removed, the monolayer washed, 
and the incubation continued for 105 or 90 min, respectively,  in 
peroxide-free  HBSS/A.  At the end of the 2-h experiment,  PMN 
adhesion to the pulsed or continuously treated monolayers was ex- 
amined as described under Fig.  1. The shaded portion of the bar 
shows the period during which peroxides  were present,  and the 
striped bar shows the length of  the subsequent peroxide-free incuba- 
tion. The basal adhesion in this experiment was  13%, which was 
subtracted  from the values  shown. 
treated smooth muscles cells: in the same experiment adher- 
ence to endothelial  cells was 40%).  We conclude that the 
generation of an adhesive surface was not a general response 
of cells to oxidant stress. 
Induction  of  PMN  binding  required  that  the  oxidant- 
treated endothelial cells be viable.  We fixed the endothelial 
cell  monolayer  with  glutaraldehyde  or  by  microwave  ir- 
radiation  (2),  and  then  exposed  them  to  either  1-1:O2 or 
t-BuOOH. There was no increased adhesion of PMN to en- 
dothelial cells that had been fixed before oxidant exposure 
(not  shown).  In contrast,  endothelial  cells  that  were  first 
treated  with TNF-ct,  H20: or t-BuOOH and then  fixed by 
either  method did  demonstrate  increased  PMN  adherence 
(not shown). 
We used phase-contrast microscopy to examine endothe- 
lial cells that had been treated with H202 or t-BuOOH, and 
throughout the experiment.  However, the pulse with H202 
had to extend for at least 30 min, and even then it was only 
40%  as  effective  as  a  continuous  2-h  exposure  of  the 
monolayer to H202.  This  experiment  showed that the pro- 
cess induced by treatment of endothelial cells with peroxide 
was self-sustaining once oxidation had been initiated. 
The nature of the protocol that we employed,  where the 
PMNs were not exposed to peroxide, suggested that oxidant- 
induced PMN adhesion described in Figs.  1 and 2  was an 
endothelial cell-dependent process.  To confirm this and to 
determine if an active PMN response was required for adher- 
ence, we used several strategies.  PMN-dependent adhesion 
requires that the adhesive glycoprotein complex CD11/CD18 
be activated (39). We found that mAb 60.3, which blocks the 
function of this class of integrins (39), failed to prevent the 
adherence induced by either H202 or t-BuOOH (not shown). 
We also found that there was little diminution of adherence 
in response to oxidant treatment when the PMN were first 
fixed  by  treatment  with  formaldehyde  (Fig.  3).  That  this 
effectively prevented PMN-dependent processes was shown 
by the lack of adherence in response to direct PMN agonists, 
10  -7 M  phorbol myristate acetate or 10 #M A23187 (Fig. 3 
legend). In addition, we found that direct treatment of PMN 
with peroxides under the conditions of  these experiments did 
not induce them to become adhesive (not shown). Therefore, 
PMN adherence to oxidant-treated endothelial cells was an 
endothelial  cell-dependent  process that required  no active 
response from the adherent PMN. 
We asked whether the generation of an adhesive surface 
after treatment with the peroxides was a response specific to 
endothelial cells. We treated cultured human smooth muscle 
cells with either 250 #M H202 or t-BuOOH for 2  and 4  h. 
These cells normally do not bind,  nor can they be induced 
to bind,  PMN.  This treatment did not alter the number of 
PMNs that adhered to these cells (5 vs 3 % adherence to un- 
Figure  3.  Adhesion of fresh or formaldehyde-fixed  PMN to en- 
dothelial  cells treated  with menadione,  H202, or t-BuOOH. En- 
dothelial  cells  were treated  with HBSS/A, or 300 #M t-BuOOH, 
1 mM H2Oz, 250 #M menadione, or 1,000 U TNF-a in HBSS/A. 
After 4 h of incubation at 37  °, the incubation buffer was removed 
and the monolayer washed twice.  The ability of the incubated  en- 
dothelial  cell monolayers to bind PMN was determined as in Fig. 
1. PMNs were either freshly isolated,  Or had been fixed with form- 
aldehyde (Materials  and Methods). Not shown is the effect of fixa- 
tion on PMN adherence in response to direct stimulation  of PMN 
with PMA, or stimulation  of both cell types with A23187.  Endo- 
thelial cell monolayers were incubated with HBSS/A for 3 h 55 rain, 
washed with HBSS/A, A23187 (10 ttM) in HBSS/A was added, and 
then 5 min later fresh or fixed PMNs were added. This measured 
adherence  in response to both PMN-dependent and endothelial 
cell-dependent mechanisms.  When PMA (10  -7 M) was the agon- 
ist, it was added directly to PMN overlying endothelial  cell mono- 
layers at the initiation  of the adherence assay, so that only PMN- 
dependent adherence was measured.  Fresh PMN adhered to the 
monolayer (buffer, 4  +  1%; A23187, 75 +  2%; PMA, 81 :t: 6%), 
but fixed PMN did not (buffer, 3 -1- 0%; A23187,  10 +  2%; PMA, 
3 +  1%). Data are expressed  as the percent of adherent cells com- 
pared to total cells added to each well, and axe presented as a mean 
and range of duplicate  values. 
The Journal of Cell Biology, Volume  112, 1991  752 Figure 4.  Morphology and integrity of endothelial cells treated with t-BuOOH or H202. Growth medium was removed from confluent 
monolayers of endothelial cells, they were washed twice with HBSS/A, and then exposed to 2.8/~M carboxyfluorescein acetoxymethyl 
ester or control buffer for 5 min. These monolayers  were washed, incubated in HBSS/A for 2 min to allow the methyl ester to be hydrolyzed, 
and then washed twice with HBSS/A before addition of oxidants. Fresh HBSS/A with or without 250 #M H202 or t-BuOOH was layered 
over the cells, and after 2 and 4 h of incubation at 37  ° the cells were examined by phase-contrast microscopy. The anuclear, uniformly 
stained objects found after 4 h of t-BuOOH treatment are blebs that are still attached to the monolayer and are not in this focal plane. 
Monolayers labeled with carboxyfluorescein were examined by fluorescence microscopy using a Nikon B1  filter cube. Exclusion of 
propidium iodide was determined using monolayers exposed to HBSStA or peroxides for 0,  115, or 235 rain. These monolayers were 
washed, incubated with 50 ~M propidium iodide for 5 min, and then washed twice before examination by fluorescence microscopy. 
found that the morphology of these monolayers differed from 
control monolayers and from each other (Fig. 4). A typical 
H202-treated  monolayer appeared pyknotic and desiccated. 
Additionally, the cells often had retracted so that the mono- 
layer developed large gaps. This, however,  did not account 
for the increased PMN adherence as visual inspection showed 
that the majority of the PMN was adherent to endothelial 
cells, and not the exposed substrate.  Furthermore, endothe- 
lial cells exposed to 2.5/zg/ml cytochalasin B displayed ex- 
treme cellular retraction, but no increase in PMN adherence 
(not shown). In contrast to the appearance of H~O2-treated 
monolayers, the nuclei of t-BuOOH-treated endothelial cells 
were  distorted  and  swollen  (Fig.  4).  Additionally,  within 
several  hours the  cells  developed blebs  that  subsequently 
pinched off from the cell surface. The marked differences in 
the appearance of  monolayers treated with H~O~ or t-BuOOH 
suggested that the mechanisms of action of  the two peroxides 
also might be different. 
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Peroxide-treated Endothelial Cells by Antioxidants and 
Iron Chelators 
Agonist 
t-BuOOH  H202  TNF-o~ 
% Inhibition 
Butylated hydroxytoluene*  91  +  1  70  +  1  14 
NDGA  63  +  3  23  +  4  31 
Aseorbate  88  +  4  92  +  l  0 
c~,o~-dipyridyl  94  +  1  44  +  0  0 
Desferal  100  +  0  88  +  3  10 
Endothelial cell monolayers were incubated for 2 h  with HBSS/A, 250 #M 
t-BuOOH or H20~, or 500 U/ml TNF-o. PMN adherence was determined as 
described under Fig.  1. The data represent five separate experiments. These 
effectors did not affect PMN-dependent adherence, as determined by adherence 
to a gelatin matrix in response to  1 nM PAF. 
* Effcctor concentrations were:  50 #M butylated hydroxytoluene; 0.1  mM 
nordihydroguiaretic acid (NDGA); 0.1 mM ascorbate; 2 mM ¢x,c~-dipyridyl; 
20 mM Desferal. 
The effect that oxidant exposure had on the viability of the 
endothelial cell monolayer was assessed by examining the 
retention of  carboxyfluorescein, a negatively charged, water- 
soluble fluorescent dye, that had been introduced into the 
cells before their exposure to peroxide. Fig. 4 shows that en- 
dothelial cells were highly fluorescent after labeling, and that 
they retained the carboxyfluorescein dye after 2  h  of ex- 
posure to either H202 or t-BuOOH. We also found (Fig. 4) 
that the cells excluded propidium iodide, which stains the 
nucleus of dead cells,  and trypan blue (not shown) after 
2  h  of treatment  with  the  oxidants.  Half of the  cells  in 
monolayers  exposed  to  H202  for  4  h  still  retained  car- 
boxyfluorescein and excluded propidium iodide, but few of 
the cells treated with t-BuOOH maintained a functional per- 
meability barrier. Lysis of the monolayer by a brief exposure 
to digitonin or Triton X-100 immediately decreased cellular 
fluorescence to background levels, showing that the dye was 
not retained by the oxidant-treated cells by interaction with 
cellular components.  Viability, as measured by dye reten- 
tion,  correlated with the ability of monolayers to recover 
their normal morphology after exposure to the peroxides: 
monolayers that were treated for 4  h  with H202,  washed, 
and returned to growth medium for 16 h appeared healthy, 
while those exposed to t-BuOOH for the same period did not 
recover their usual morphology. These results show that ex- 
pression of the pro-adhesive surface was a function of viable 
cells, but that lethally injured cells still remained adhesive 
for PMN. 
Generation of the Endothelial Cell Pro-adhesive 
Surface Is a Response to Oxygen Radicals 
The appearance of the adhesive endothelial cell surface was 
the result of oxidative reactions carried out in or near the en- 
dothelial ceils. First, PMN adherence was dependent on the 
peroxide  function  of t-BuOOH,  as  treatment  of the  en- 
dothelial cell monolayers with equivalent concentrations of 
t-butanol did not promote PMN adherence (not shown). Sec- 
ond,  PMN adherence was  also induced by intracellularly 
generated  oxygen  radicals.  Endothelial  cell  monolayers 
treated with menadione, a quinone that undergoes reductive 
cycling with the production of 02- and H202 (29,  31),  also 
became adhesive for PMN (Fig. 3). Adherence in response 
to menadione usually was less than that induced by max- 
imally effective concentrations of t-BuOOH (n  =  8). 
The third line of evidence that the peroxide induction of 
endothelial cell-dependent PMN adhesion required intracel- 
lular metabolism was that this process required intracellular 
iron. Transition metals, such as iron, have peroxidase activ- 
ity and catalyze radical formation during peroxide break- 
down (25).  We found that adherence in response to either 
H202 or t-BuOOH was inhibited by coincubation with the 
Fe  +3  chelator  desferal  (Table I).  The  essential  Fe  +3  was 
localized within the endothelial cells because conalbumin, a 
chicken transferrin  not  transported  by  human  cells,  was 
unable to inhibit the adhesion induced by either H202 or 
t-BuOOH (not shown).  In contrast to the results obtained 
with t-BuOOH or 1-1202, PMN adhesion induced by endothe- 
lial cell metabolism of menadione was not blocked by des- 
feral (28 +  2 % adherence with 20 mM desferal, 26 +  2 % 
without desferal; unstimulated adherence was 5 +  1%). The 
impression that there were differences in the mechanism of 
action of these oxidants was strengthened when the effect of 
the hydrophobic transition metal chelator, a,a~dipyridyl, on 
endothelial cell-dependent adhesion  was  examined,  a,~ 
Dipyridyl  blocked almost all of  the adhesion due to t-BuOOH, 
while it inhibited  only 44%  of the  adhesion  induced by 
H202.  These chelators did not affect TNF-ot-induced ad- 
herence. These results suggest that the exogenous peroxides 
had to be metabolized to more potent oxidizing radicals in 
an intracellular, iron-dependent reaction, while direct intra- 
cellular generation of oxygen free radicals did not require 
free iron to exert their effects. 
Finally, we used free radical scavengers to directly test 
whether induction of the pro-adhesive state by peroxides was 
due to radical formation. Butylated hydroxytoluene, a lipid- 
soluble antioxidant, effectively inhibited adherence induced 
by either H202 or t-BuOOH (Table I). Nordihydroguaiartic 
acid,  an inhibitor of lipoxygenase-catalyzed reactions and 
a  nonspecific inhibitor of radical reactions, also inhibited 
PMN adhesion, but not as effectively  as butylated hydroxytol- 
uene. Ascorbate, a water-soluble antioxidant, inhibited 90 % 
of the  adherence induced by either H202  and  t-BuOOH. 
Thus,  termination of oxidative radical  chain reactions by 
lipid- or water-soluble antioxidants prevented the appear- 
ance of the adhesive endothelial cell surface that resulted 
from peroxide exposure. 
PAF Does Not Mediate Adherence after Prolonged 
Oxidant Exposure 
Our initial experiments to identify the molecular mechanism 
of adherence in response to prolonged oxidant exposure ex- 
amined the  potential  role of endothelial cell  PAF  in  this 
event. We first examined the time course of PAF synthesis 
after oxidant exposure by pulse labeling the cultures with 
[3H]acetate for 10 min throughout the incubation (24). We 
found (Fig. 5 a) that 250 #M H202 induced PAF synthesis 
immediately after exposure to H202 and during the subse- 
quent half-hour of exposure. This synthesis had fallen to un- 
detectable levels after 60 min of exposure. In a separate ex- 
periment (not shown), there was no detectable synthesis of 
[3H]PAF at either 100 or 240 min of stimulation with H202. 
The effect of t-BuOOH on the endothelial cells differed from 
that of H202  in that there was  no detectable synthesis of 
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bin; (B) effect as a function of time of a PAF receptor antagonist on PMN adherence.  Endothelial cells were washed with I-IBSS/A and 
at time =  0 the buffer was switched to 37* HBSS/A with or without 250 #M t-BuOOH,  250 ttM 1-1202 or 2 U/ml human thrombin. 
10 min before the stated time, 25 #Ci of [3H]acetate was added to the incubation medium, and the incubation with the radiolabel was 
allowed to continue for 10 min at 37 °. Incorporation of [3H]acetate was stopped by removing the incubation  medium (<1% of the [3H]PAF 
is released  into the overlaying medium) and adding 1 ml methanol to the monolayer.  [3H]PAF was quantitated using total radioactivity 
in the lipid extract and the ratio of [3H]PAF to recovered radioactivity from the chromatography  plate. In B, endothelial cell monolayers 
were washed  and treated  with HBSS/A  with or without 350 ~M  H202  for the stated  period of time. This was then removed,  the 
monolayers washed, and PMN that had been preincubated for 5 min with 100 #M L659,989, or an equivalent mount of DMSO vehicle, 
were layered over the monolayer. This allowed the concentration of L659,989 to be maintained at 100/~M throughout  the coincubation. 
Nonadherent PMNs were removed and the tightly adherent PMNs were quantitated as in Fig. 1. When the effect of a second PAF receptor 
antagonist, WEB 2086, was examined (not shown) its concentration  was 10 #M, and the concentration  of H202 or t-BuOOH was 250/~M. 
The incubation  time was 2 h. In parallel experiments,  both L659,989 and WEB 2086 inhibited PAF-induced PMN adherence to a gelatin 
matrix in a fashion that depended on the concentration of PAE Data are expressed  as a mean and range of duplicate values. 
Figure  6.  Adherence of PMN or undifferentiated  HL-60 cells to 
endothelial cells stimulated with menadione, t-BuOOH, or ["[202. 
Endothelial cells grown to confluence were treated with HBSS/A, or 
300/~M t-BuOOH, 1 mM H202, 300 ttM menadione, or 1,000 U 
TNF-ct in I-IBSS/A. After 4 h of incubation at 37", the incubation 
medium was removed, and the monolayer washed twice before the 
ability of the incubated endothelial cell monolayers to bind rain_ 
PMN or mln-HL-60  cells was determined as described under Fig. 
1 using a 5-min incubation period. The values presented are the 
percent of cells that bound compared to the total added to each 
well,  and are given as a mean and range of duplicate  values. 
Figure  7.  Effect of actinomycin D or emetine on PMN adherence 
to endothelial cells treated with t-BuOOH, H202, or TNF-a. En- 
dothelial ceils were treated  for 15 min at 37 ° with or without 5 
/~g/ml of actinomycin D or 5 #M emetine in I-IBSS/A. The cells 
were  washed,  and then treated  with  HBSS/A  buffer, or 250/~M 
t-BuOOH, 250 #M H202 or 1,000 U TNF-ot in I-IBSS/A for 2 h at 
37 ° in the continued presence of the protein synthesis inhibitors. 
The incubation  buffer was removed, the monolayers were washed 
twice, and PMN adherence was measured as described under Fig. 1. 
Data are expressed as the percent of adherent cells compared to to- 
tal cells added to each well, and are presented as a mean and range 
of duplicate values. 
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Figure 8. Effect of t-BuOOH 
on GMP-140 surface  expres- 
sion,  von Willebrand  Factor 
release,  and PMN adherence 
as a function of time.  Endo- 
thelial  cells  were  treated  at 
37  ° with HBSS/A with or with- 
out 250 #M t-BuOOH for the 
stated time. Supematants were 
removed  to  determine  vWF 
release, while the monolayers 
were  fixed and  stained  with 
the  anti-GMP-140 mAb  S12 
as described  under Materials 
and Methods. Determination of 
PMN adherence was performed 
in parallel as described under 
Fig.  1.  There was no detect- 
able increase  in  S12 binding 
to monolayers incubated with 
HBSS/A alone, nor was there 
an increase in binding of the 
isotype-matched irrelevant an- 
antibody  associated  with the 
[3H]PAF  at any of the times examined. We next examined 
the ability of endothelial cells to retain for prolonged times 
the PAF synthesized immediately upon exposure to H202. 
We  continuously  exposed  endothelial  cells  to  H202  and 
[3H]acetate (four times the amount of [3H]acetate used in 
the  pulse  labeling  experiment)  and  then  extracted  and 
purified cellular PAE There was no detectable [3H]PAF re- 
maining in the exposed cells after 90 or 120 min of stimula- 
tion (not shown). 
We employed L659,989,  a competitive antagonist of the 
PAF-receptor (10),  to directly assess the role of endothelial 
cell-associated PAF as a signal for the adherence of PMN. 
As we previously observed, exposure of endothelial cells to 
H202  for  short  periods  of time induced  PMN  adherence 
(14) (Fig. 5 b). L659,989 inhibited 64 % of the PMN adher- 
ence induced by exposure of endothelial cell monolayers to 
1-1202 for 30 min. However, after 1 h of exposure, L659,989 
had  no  measurable  effect on  H202-induced  PMN  adher- 
ence.  We confirmed this resuk with a second,  structurally 
unrelated receptor antagonist, WEB 2086, which also had no 
effect  on  t-BuOOH-  or  TNF-oMnduced  adherence  (not 
shown).  These  results  show  that  while  H202  induces  en- 
dothelial cells to bind PMN by a PAF-dependent mechanism 
soon after exposure to it, this mechanism does not account 
for PMN adherence after exposure to I-I202 for 60 min or 
longer, and plays no role in t-BuOOH-induced adhesion at 
any time. 
ELAM-1 Does Not Mediate Adherence after 
Oxidant Exposure 
ELAM-1 directly mediates neutrophil,  monocyte, and HL- 
60 cell adherence to endothelial cells activated with cyto- 
kines such as TNF-o~ (3), and is the sole known mechanism 
by which PMNs adhere to endothelial cells with a prolonged 
time course.  We investigated the role of ELAM-1  in PMN 
adhesion to oxidant-treated endothelial  cells using HL-60 
cells as a probe for the expression of ELAM-1. The data in 
Fig. 6 show that although the oxidants induced PMN adher- 
ence in this experiment, they uniformly failed to stimulate 
the adherence of undifferentiated HL-60 cells. We also ex- 
amined the effect of protein synthesis inhibitors on the devel- 
opment of the pro-adhesive surface. This approach relied on 
the observation that endothelial  cells do not normally ex- 
press either ELAM-1 or its messenger RNA (3,  4).  Treat- 
ment of endothelial cell monolayers with actinomycin D, an 
inhibitor  of transcription,  failed  to  inhibit  adherence  in 
response  to  250  #M  H202  or  t-BuOOH  even  though  it 
blocked 70% of the adherence induced by TNF-a (Fig. 7). 
A similar effect was obtained when emetine was used to in- 
hibit translation. Finally, as a direct and independent assess- 
ment of the role of ELAM-1, we employed H18/7, an mAb 
against ELAM-1 that blocks about one-half of the adherence 
induced  by  TNF-o~  (3).  In  this  one  experiment,  H18/7 
blocked 50% of  the adherence induced by TNF-~, as expected, 
but failed to inhibit adherence in response to t-BuOOH (not 
shown).  These results exclude ELAM-1, or any newly syn- 
thesized  protein,  as  the  mechanism  for the  adherence  of 
PMN to oxidant-treated endothelial cells. 
GMP-140 Mediates Adhesion after Prolonged Exposure 
of Endothelial Cells to Peroxides 
GMP-140 is a recently characterized glycoprotein that has a 
predicted structure similar to that of ELAM-1  (ll).  It is a 
membrane-bound component of specialized granules in en- 
dothelial cells,  the Weibel-Palade bodies,  that are rapidly 
translocated to the cell surface in response to agonist stimu- 
lation (5, 9). GMP-140 mediates PMN adhesion to appropri- 
ately stimulated endothelial cells, GMP-140-coated surfaces, 
and COS cells transfected with its cDNA (7). Therefore, we 
asked whether treatment of endothelial cell monolayers with 
peroxide induced the translocation of GMP-140 to the cell 
surface. We found (Fig.  8) increased surface expression of 
GMP-140  as determined  by increased binding  of S12,  an 
mAb  against  GMP-140,  on  endothelial  cells  treated  with 
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Figure 9. Effect of an mAb, G1, that blocks GMP-140 function on 
PMN adherence to endothelial cells treated with (a) t-BuOOH or 
(b) H202. Endothelial cells were treated at 37 ° for the stated time 
with HBSS/A, 250 #M t-BuOOH, or 250 #M H202 in HBSS/A. 
The  incubation buffer was removed and the monolayer was in- 
cubated for  10 min at 37 ° in I-IBSS/A  with 10 #g/ml GI or the 
isotype-matched mAb S12. S12 also recognizes GMP-140 but does 
not block its function (7). mln-PMN adherence was measured as 
described under Fig. 1. Data are expressed as the percent of adher- 
ent  cells compared  to total  cells added to each  well, and  are 
presented as a mean and range of duplicate values. 
ence to endothelial cells that had been exposed to H202 or 
t-BuOOH for 1--4 h. The isotype-matched mAb S12, which 
binds to a different epitope on GMP-140 and does not block 
its function (7), did not affect PMN adherence. 
We also found that PMN adherence to peroxide-treated en- 
dothelial cells could be inhibited by pretreating the PMN with 
solubilized, purified GMP-140 (Fig.  10).  Excess GMP-140 
completely suppressed  adhesion to both 1-1202- and t-BuOOH- 
treated endothelial  cell  monolayers, and,  since the PMNs 
were not aggregated, this effect was not due to an artifactual 
decrease in available PMN. Control incubations showed that 
the interaction between PMN and oxidant-treated endothelial 
cells was not affected by an irrelevant protein, fibrinogen, and 
that excess GMP-140 did not inhibit PMN adherence to endo- 
thelial cells expressing ELAM-1 in response to TNF-a stimu- 
lation. Our experiments demonstrated that, in response to ox- 
idant treatment, human endothelial cells express GMP-140 
for prolonged periods of time, and that it is the sole mecha- 
nism for the increased adhesion of  PMN to oxidant-perturbed 
endothelial cell monolayers. 
Discussion 
We demonstrated that primary cultures of endothelial cells 
became  adhesive  for  PMN  after  treatment  either  with  a 
water-soluble or a lipid-soluble peroxide, or after intracellu- 
lar generation of oxygen radicals.  The increase in adhesion 
was equivalent to that induced by cytokine stimulation, up 
to  10-fold  over basal values,  but was not due to the same 
adhesion  mechanism.  Formation  of the  adhesive  surface 
could be initiated by a short exposure of the endothelial cells 
to the oxidants, and clearly preceded irreversible oxidative 
damage to the cells.  Adherence of PMN to oxidant-treated 
endothelial cells was due to an alteration of the endothelial 
cells themselves, rather than the activation of the adhesive 
response  of PMN.  Although H20~ can directly  stimulate 
t-BuOOH. The time-dependent increase in surface expres- 
sion of GMP-140 paralleled the increase in PMN adhesion. 
A  soluble component of Weibel-Palade bodies,  vWF,  was 
secreted into the culture supernatant in response to treatment 
with t-BuOOH, confirming that Weibel-Palade bodies had 
fused  with  the  plasma  membrane.  Parallel  experiments 
showed that monolayers treated  with buffer alone did  not 
demonstrate increased S12 binding, that there was no corre- 
sponding  increase  in  binding  of T10  (a  platelet-specific 
isotype-matched antibody), and that in the absence of the 
primary antibody, there was no increase in binding of the 
leSI-labeled second antibody (not shown). Since HeO2-treat- 
ment also induced increased binding of S12 mAb (not shown), 
prolonged exposure to peroxides induced the translocation 
of Weibel-Palade  bodies  containing GMP-140  to  the  cell 
surface. 
We next used G1, an rnAb against GMP-140 that blocks PMN 
adhesion to GMP-140-coated surfaces and blocks PMN adhe- 
sion to endothelial cells expressing GMP-140 (7), to deter- 
mine if the newly expressed GMP-140 was responsible for 
the adhesion of PMN to peroxide-treated endothelial cells. 
We found (Fig. 9) that G1 completely inhibited PMN adher- 
Figure 10.  Effect of soluble GMP-140 on PMN adherence to per- 
oxide-treated endothelial cells. Endothelial cells were treated for 
2 h at 37 ° with HBSS/A, 250 #M t-BuOOH, or 350/~M  H20~ 
in HBSS/A. The incubation buffer was removed, the monolayers 
washed, and PMNs that had been pretreated for 20 min at 25  ° with 
5 ~g/ml of either soluble GMP-140 or fibriuogen were then added 
to the endothelial cells. PMN adherence was measured as described 
under Fig. 1. Data are expressed as the percent of adherent cells 
compared to total cells added to each well, and are presented as a 
mean and range of duplicate values. 
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and our preliminary data showed a similar direct activation 
of PMN adhesion by high concentrations of peroxides (not 
shown), there were insufficient residual peroxides remaining 
in the system to induce this response. This was verified by 
demonstrating that PMN did not adhere to a human smooth 
muscle cell line, and that the mAb 60.3 did not block the ad- 
herence of PMN to oxidant-treated endothelial cells. Addi- 
tional evidence that this was an endothelial cell-dependent 
process was the ability of  formaldehyde-fixed  PMN to adhere 
to oxidant-treated endothelial cells.  This observation also 
demonstrated that the adhesive mechanism required no ac- 
tive response from the PMN. 
The pro-adhesive molecule expressed by the oxidatively 
stressed endothelial cells was not the phospholipid PAF, al- 
though  this  lipid  does  mediate  PMN  adherence  to  en- 
dothelial cells treated with H202 for shorter periods of time 
(14) (Fig. 6). The surface expression of this potent phospho- 
lipid mediates PMN-endothelial cell adherence under other 
circumstances (14, 23, 24, 40, 42), but our data showed that 
there was little or no PAF present at the times examined here. 
Furthermore, we were unable to detect significant synthesis 
and accumulation of  PAF in response to t-BuOOH treatment, 
even though it induced as much adherence as H202. As ex- 
pected from these observations, PAF receptor antagonists 
failed to antagonize PMN adherence in response to pro- 
longed peroxide treatment. 
We  found that  PMN  adherence  to  oxidant-treated  en- 
dothelial cells did not require de novo protein synthesis. This 
suggested a role for a preformed mediator, and eliminated a 
role for ELAM-1 in this process. The lack of an effect by the 
mAb H18/7,  directed against ELAM-1, supported this con- 
clusion. Further evidence that ELAM-1 was not involved was 
the complete lack of adherence of the myelocytic cell line 
HL-60 to the oxidant-treated cells.  The failure of HL-60 
cells to bind was not expected as HL-60 cells, and mono- 
cytes, also bind to GMP-140 (7, 13). Indeed, treatment of  hu- 
man umbilical vein endothelial cells with a different lipid- 
soluble peroxide, cumene hydroperoxide, induces monocyte 
adherence to the exposed monolayer (26). One potential ex- 
planation is that the recloned line of HL-60 cells that we em- 
ployed recognized ELAM-1  (since they bound to TNF-~x- 
treated ceils), but not GMP-140. If true, this would suggest 
that HL-60 cells possess different receptors for these selec- 
tions that can be independently expressed. 
The sole molecular mechanism responsible for the adher- 
ence of PMN to endothelial cell monolayers treated with low 
concentrations of oxidants for prolonged periods of time was 
the expression of GMP-140 on the cell surface.  This was 
demonstrated by the complete inhibition of adherence by an 
mAb that blocks GMP-140-mediated PMN adherence, and 
by competitively blocking GMP-140 receptors on PMN with 
solubilized GMP-140.  There was  a  marked difference be- 
tween the expression of GMP-140 after oxidant treatment 
and its expression after stimulation of the endothelial cells 
with the rapidly acting agonists histamine or thrombin  2 (9). 
We  found that GMP-140 was  expressed on the peroxide- 
treated  endothelial  cells  over a  period  of several  hours, 
which is in sharp contrast to its transient expression after 
stimulation with the rapidly acting agonists where its pres- 
ence on the cell surface is measured in just minutes (9). We 
have not identified the reason for this difference, but it is pos- 
sible that the mechanisms responsible for its reinternaliza- 
tion (9) were not induced by the oxidizing agents, or that this 
mechanism was impeded by the oxidants.  Also, peroxide- 
treated endothelial cells bound more PMN than did thrombin- 
treated monolayers, even though thrombin is a potent agonist 
for GMP-140 expression (9). Again, this may relate to the 
inability of peroxide-treated cells  to  reinternalize surface 
GMP-140,  resulting in a higher steady-state abundance of 
GMP-140.  Alternatively, it may reflect the lack of synthesis 
of PMN inhibitory compounds that decrease PMN adhesion 
to activated endothelial cells (38). The overall effect, how- 
ever, is to produce an endothelial surface with very high 
adhesivity for prolonged times that is completely due to ex- 
pression of GMP-140.  This is in contrast to rapidly acting 
agonists  where adhesion  results  from both GMP-140 and 
PAF expression  2,  and in contrast to adhesion induced by 
short exposures to higher concentrations of H202, which is 
solely due to the expression of PAF (14). 
The mechanism by which oxidants induced the transloca- 
tion of GMP-140 from the Weibel-Palade bodies to the cell 
surface is not known, but free radicals were essential compo- 
nents. Free radicals have previously been shown to trigger 
exocytosis of histamine-containing granules from mast cells 
(18). In our experiments, there were differences  between rad- 
ical generation by H202 and t-BuOOH: t-BuOOH-mediated 
adherence was more sensitive to the actions of a hydrophobic 
iron chelator and lipid-soluble antioxidants. This suggests 
that the effects of both peroxides were mediated by the iron- 
catalyzed propagation of free radical oxidation reactions, but 
that lipid-soluble radicals (perhaps t-BuOO radicals) were 
essential intermediates in t-BuOOH-mediated GMP-140 sur- 
face expression. The lack of effect of conalbumin, a transfer- 
rin that is not translocated by human cells, suggests that the 
iron-catalyzed reactions occurred within  the  intracellular 
compartment. This is consistent with our observation that 
menadione,  an  intracellular source of 02- and  H202  (29, 
31),  also  resulted in  the  formation of a  pro-adhesive en- 
dothelial cell surface. However the effect of menadione, un- 
like peroxide-stimulated GMP-140 expression, did not de- 
pend on free iron, a result also observed during the study of 
menadione-induced toxicity (17). Since the formation of rad- 
icals by alternative methods circumvents the requirement for 
iron, the essential role for ionic iron shows  that H202  and 
t-BuOOH must be metabolized to free radicals in order to 
induce GMP-140 expression. 
Extracellular generation of peroxides and oxidizing radi- 
cals might also induce GMP-140 translocation, and a poten- 
tial source of these could be the radicals produced by acti- 
vated neutrophils.  Such radicals damage endothelial cells 
(12,  16, 35, 36), and do so in an iron-dependent fashion (12, 
35). Thus extravascular PMN, when stimulated by appropri- 
ate agonists to produce oxidizing radicals, would be able to 
recruit other, circulating PMN by alteration of the intravas- 
cular surface. Endothelial cells have been widely employed 
as a target for oxidizing reagents because of the relevance of 
this model to a large number of diverse and important dis- 
ease  processes  including  adult  respiratory  distress  syn- 
drome, reperfusion injury, and atherosclerosis (15, 19, 32, 
37).  Recruitment of PMN to the sites of oxidative damage 
may serve to enhance the fundamental pathologic events and 
thereby exacerbate the disease process. Induction of Weibel- 
Palade body translocation to the cell surface and the attendant 
The Journal of Cell Biology, Volume 112,  1991  758 expression of GMP-140 on the surface of these endothelial 
cells may be one mechanism involved in the etiology of these 
diseases. 
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